AdminNov 4, 2020< 1 min read

Optimal Synthesis of Clinical Trial Data

2022-02-19-Synthetic-Data-Generation-101-3

Khaled El Emam, SVP & GM, Replica Analytics

Presentation describing a method for the synthesis of complex clinical trial data and explaining how to tune its hyperparameters, with results presented on multiple oncology clinical trial datasets.

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.

Learn More

RELATED ARTICLES

AetionJul 22, 2025< 1 min read

Hope is Not a Strategy: Using Robust Real-World Evidence to Make Better Clinical Development Decisions

Real-world evidence (RWE) has the power to guide smarter decisions throughout the development lifecycle. To fully unlock that ...

Laura Serra FarrerasJul 16, 20253 min read

The New Shape of Aetion: A Visual System for a Unified Product Suite

In real-world evidence, clarity is key.

AetionJul 9, 20254 min read

Built for Compliance: How Aetion® Delivers Regulatory-Grade Real-World Evidence

Nataile Schibell, MPH and Pippa Hodgkins